A minimal common outcome measure set for COVID-19 clinical research

Marshall, John C.; Murthy, Srinivas; Diaz, Janet; Cheng, Allen; Denholm, Justin; Hodgson, Carol; Tong, Steven; Webb, Steve; Bozza, Fernando Augusto; Adhikari, N. K.; Foster, Nadine; Fowler, Rob; Turgeon, Alexis; Xiaobin, Feng; Ruijin, Qiu; Lei, Shi; Junhua, Zhang; Kojan, Richard; Malvey, Denis; Bauer, Michael; Brunkhorst, Frank; Glueck, Thomas; Wolf, Timo; Gomersall, Charles; Kumar, Bharath; Clarke, Mike; Laffey, John; Martin-Loeches, Ignacio; Piva, Simone; Shimizu, Naoki; Phyu, Sabai; Bonten, Marc; Jong, Menno de; Derde, Lennie; Netea, Mihai; Veerdonk, Frank van de; McArthur, Colin; McBride, Stephen; McGuinness, Shay; Morpeth, Susan; Salisu-Kabara, Halima; Sinclair, Jorge; Arabi, Yaseen M.; Kim, YaeJean; Oh, Myoung-Don; Baillie, Kenneth; Dunning, Jake; Fletcher, Tom; Gobat, Nina; Gordon, Anthony; Horby, Peter; McAuley, Danny; Merson, Laura; Williamson, Paula; Blackwood, Bronagh; Angus, Derek C.; Berry, Scott; Harhay, Michael; Needham, Dale; Uyeki, Tim; Dat, Vu Quoc

A minimal common outcome measure set for COVID-19 clinical research

Detalhes bibliográficos
Autor(a) principal:	Marshall, John C.
Data de Publicação:	2020
Outros Autores:	Murthy, Srinivas, Diaz, Janet, Cheng, Allen, Denholm, Justin, Hodgson, Carol, Tong, Steven, Webb, Steve, Bozza, Fernando Augusto, Adhikari, N. K., Foster, Nadine, Fowler, Rob, Turgeon, Alexis, Xiaobin, Feng, Ruijin, Qiu, Lei, Shi, Junhua, Zhang, Kojan, Richard, Malvey, Denis, Bauer, Michael, Brunkhorst, Frank, Glueck, Thomas, Wolf, Timo, Gomersall, Charles, Kumar, Bharath, Clarke, Mike, Laffey, John, Martin-Loeches, Ignacio, Piva, Simone, Shimizu, Naoki, Phyu, Sabai, Bonten, Marc, Jong, Menno de, Derde, Lennie, Netea, Mihai, Veerdonk, Frank van de, McArthur, Colin, McBride, Stephen, McGuinness, Shay, Morpeth, Susan, Salisu-Kabara, Halima, Sinclair, Jorge, Arabi, Yaseen M., Kim, YaeJean, Oh, Myoung-Don, Baillie, Kenneth, Dunning, Jake, Fletcher, Tom, Gobat, Nina, Gordon, Anthony, Horby, Peter, McAuley, Danny, Merson, Laura, Williamson, Paula, Blackwood, Bronagh, Angus, Derek C., Berry, Scott, Harhay, Michael, Needham, Dale, Uyeki, Tim, Dat, Vu Quoc
Tipo de documento:	Artigo
Idioma:	eng
Título da fonte:	Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo:	https://www.arca.fiocruz.br/handle/icict/42482
Resumo:	Fernando Bozza - Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.

Metadados do item

id	CRUZ_cde2811e4fec010419c7011f68d43481
oai_identifier_str	oai:www.arca.fiocruz.br:icict/42482
network_acronym_str	CRUZ
network_name_str	Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str	2135
spelling	Marshall, John C.Murthy, SrinivasDiaz, JanetCheng, AllenDenholm, JustinHodgson, CarolTong, StevenWebb, SteveBozza, Fernando AugustoAdhikari, N. K.Foster, NadineFowler, RobTurgeon, AlexisXiaobin, FengRuijin, QiuLei, ShiJunhua, ZhangKojan, RichardMalvey, DenisBauer, MichaelBrunkhorst, FrankGlueck, ThomasWolf, TimoGomersall, CharlesKumar, BharathClarke, MikeLaffey, JohnMartin-Loeches, IgnacioPiva, SimoneShimizu, NaokiPhyu, SabaiBonten, MarcJong, Menno deDerde, LennieNetea, MihaiVeerdonk, Frank van deMcArthur, ColinMcBride, StephenMcGuinness, ShayMorpeth, SusanSalisu-Kabara, HalimaSinclair, JorgeArabi, Yaseen M.Kim, YaeJeanOh, Myoung-DonBaillie, KennethDunning, JakeFletcher, TomGobat, NinaGordon, AnthonyHorby, PeterMcAuley, DannyMerson, LauraWilliamson, PaulaBlackwood, BronaghAngus, Derek C.Berry, ScottHarhay, MichaelNeedham, DaleUyeki, TimDat, Vu Quoc2020-07-31T00:50:31Z2020-07-31T00:50:31Z2020MARSHALL, John C. et al. A minimal common outcome measure set for COVID-19 clinical research. The Lancet Infectious Diseases, v. 20, n. 8, p. 192-197, 2020.1473-3099https://www.arca.fiocruz.br/handle/icict/4248210.1016/S1473-3099(20)30483-71474-4457Fernando Bozza - Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection: John C. Marshall (St. Michael's Hospital. Toronto, Canada); Srinivas Murthy (BC Children's Hospital. Vancouver, BC, Canada), Janet Diaz (San Francisco Veterans Affairs Health Care System. San Francisco, CA, USA), Neil Adhikari (University of Alberta. Faculty of Medicine and Dentistry. Department of Critical Care Medicine. Edmonton, Canada / Alberta Health Services. Edmonton, Canada), Derek C. Angus (University of Pittsburgh. Pittsburgh, PA, United States), Yaseen M. Arabi (King Saud bin Abdulaziz University for Health Sciences. Riyadh, Jeddah, Saudi Arabia), Kenneth Baillie (University of Edinburgh. Roslin Institute. Genetics and Genomics. Edinburgh, UK), Michael Bauer (Universitätsklinikum Carl Gutav Carus. Department of Psychiatry and Psychotherapy. Dresden, Germany), Scott Berry (University of Texas at Austin. Austin, Texas, United States), Bronagh Blackwood (University Belfast. Belfast, UK), Marc Bonten (Universitair Medisch Centrum Utrecht. Utrecht, Netherlands), Fernando Bozza (Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil), Frank Brunkhorst (Universitätsklinikum Jena. Jena, Thüringen, Germany), Allen Cheng (Monash University. Clayton, Australia), Mike Clarke (Queen's University Belfast. School of Medicine. Centre for Public Health. Dentistry and Biomedical Science. Belfast, UK), Vu Quoc Dat (Hanoi Medical University. Hanoi, Vietnam), Menno de Jong (University of Amsterdam. Amsterdam, Netherlands), Justin Denholm (University of Melbourne. Melbourne, Victoria, Australia), Lennie Derde (Utrecht University. Utrecht, Netherlands), Jake Dunning (Department of Health and Social Care. Public Health England. London, United Kingdom), Xiaobin Feng (Tsinghua University. Beijing, China), Tom Fletcher (Royal Liverpool University Hospital. Tropical and Infectious Disease Unit. Liverpool, UK / Liverpool School of Tropical Medicine. Liverpool, UK), Nadine Foster (Alberta Health Services. Alberta, Canada), Rob Fowler (University of Toronto. Toronto, Canada), Nina Gobat (University of Oxford. Oxford, United Kingdom), Charles Gomersall (The University of Hong Kong. Hong Kong), Anthony Gordon (Imperial College London. London, United Kingdom), Thomas Glueck (Kliniken Südostbayern. Traunstein, Bayern, Germany), Michael Harhay (University of Pennsylvania. Philadelphia, PA, United States), Carol Hodgson (Monash University. Clayton, Victoria, Australia), Peter Horby (University of Oxford. Oxford, United Kingdom), YaeJean Kim (Sungkyunkwan University. Seoul, South Korea), Richard Kojan (Alliance for International Medical Action. Paris, France), Bharath Kumar (Indian Institute of Chemical Technology. Hyderabad, India), John Laffey (National University of Ireland Galway. Galway, Ireland), Denis Malvey (Sem afiliação), Ignacio Martin-Loeches (Trinity College Dublin. Dublin, Ireland), Colin McArthur (Medical Research Institute of New Zealand. Wellington, New Zealand), Danny McAuley (Queen's University Belfast. Belfast, United Kingdom), Stephen McBride (Middlemore Hospital. Department of Infectious Diseases. Auckland, New Zealand), Shay McGuinness (Auckland District Health Board. Auckland, New Zealand), Laura Merson (University of Oxford. Oxford, United Kingdom), Susan Morpeth (Auckland District Health Board. Auckland, New Zealand), Dale Needham (The Johns Hopkins Hospital. Baltimore, United States), Mihai Netea (Radboud University. Department of Internal Medicine and Center for Infectious Diseases. Nijmegen, Netherlands), Myoung-Don Oh (Seoul National University. Gwanak-gu, South Korea), Sabai Phyu (University of Bergen. Gade Institute. Section of Microbiology and Immunology. Bergen, Norway), Simone Piva (Università degli Studi di Brescia. Brescia, Italy), Ruijin Qiu (University of Chinese Medicine. Dongzhimen Hospital. Beijing, China), Halima Salisu-Kabara (Aminu Kano Teaching Hospital. Kano, Nigeria), Lei Shi (National Clinical Research Center for Infectious Diseases. Treatment and Research Center for Infectious Diseases. The Fifth Medical Center of PLA General Hospital. Beijing, China), Naoki Shimizu (St. Marianna University School of Medicine. Department of Pediatrics. Kanagawa, Japan), Jorge Sinclair (Hospital Punta Pacífica. Johns Hopkins Medicine. Universidad de Panamá. Ciudad de Panamá, Panamá), Steven Tong (The Peter Doherty Institute for Infection and Immunity. Melbourne, Australia), Alexis Turgeon (Université Laval. Quebec, QC, Canada), Tim Uyeki (Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Influenza Division. Atlanta, Georgia, United States), Frank van de Veerdonk (Radboud University. Nijmegen, The Netherlands), Steve Webb (St. John of God Health Care. Perth, Western Australia, Australia), Paula Williamson (University of Liverpool. Department of Biostatistics. Liverpool, United Kingdom), Timo Wolf (Goethe-Universität Frankfurt am Main. Abteilung für Infektiologie. HIV-Center. Frankfurt, Germany), Junhua Zhang (Tianjin University of Traditional Chinese Medicine. Tianjin, China).Múltipla - ver em Notas.Clinical research is necessary for an effective response to an emerging infectious disease outbreak. However, research efforts are often hastily organised and done using various research tools, with the result that pooling data across studies is challenging. In response to the needs of the rapidly evolving COVID-19 outbreak, the Clinical Characterisation and Management Working Group of the WHO Research and Development Blueprint programme, the International Forum for Acute Care Trialists, and the International Severe Acute Respiratory and Emerging Infections Consortium have developed a minimum set of common outcome measures for studies of COVID-19. This set includes three elements: a measure of viral burden (quantitative PCR or cycle threshold), a measure of patient survival (mortality at hospital discharge or at 60 days), and a measure of patient progression through the health-care system by use of the WHO Clinical Progression Scale, which reflects patient trajectory and resource use over the course of clinical illness. We urge investigators to include these key data elements in ongoing and future studies to expedite the pooling of data during this immediate threat, and to hone a tool for future needs.engElsevierA minimal common outcome measure set for COVID-19 clinical researchinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleCOVID-19SARS-CoV-2Severe acute respiratoryWHO Clinical Progression Scaleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/42482/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALA minimal_Fernando_Bozza_etal_INI_2020.pdfA minimal_Fernando_Bozza_etal_INI_2020.pdfapplication/pdf418630https://www.arca.fiocruz.br/bitstream/icict/42482/2/A%20minimal_Fernando_Bozza_etal_INI_2020.pdfacf7a2557b3001ac49b59bfeb34b8cf2MD52TEXTA minimal_Fernando_Bozza_etal_INI_2020.pdf.txtA minimal_Fernando_Bozza_etal_INI_2020.pdf.txtExtracted texttext/plain33430https://www.arca.fiocruz.br/bitstream/icict/42482/3/A%20minimal_Fernando_Bozza_etal_INI_2020.pdf.txtbc400db2ca323915b46975a24368a4c2MD53icict/424822021-03-13 22:54:59.468oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-14T01:54:59Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv	A minimal common outcome measure set for COVID-19 clinical research
title	A minimal common outcome measure set for COVID-19 clinical research
spellingShingle	A minimal common outcome measure set for COVID-19 clinical research Marshall, John C. COVID-19 SARS-CoV-2 Severe acute respiratory WHO Clinical Progression Scale
title_short	A minimal common outcome measure set for COVID-19 clinical research
title_full	A minimal common outcome measure set for COVID-19 clinical research
title_fullStr	A minimal common outcome measure set for COVID-19 clinical research
title_full_unstemmed	A minimal common outcome measure set for COVID-19 clinical research
title_sort	A minimal common outcome measure set for COVID-19 clinical research
author	Marshall, John C.
author_facet	Marshall, John C. Murthy, Srinivas Diaz, Janet Cheng, Allen Denholm, Justin Hodgson, Carol Tong, Steven Webb, Steve Bozza, Fernando Augusto Adhikari, N. K. Foster, Nadine Fowler, Rob Turgeon, Alexis Xiaobin, Feng Ruijin, Qiu Lei, Shi Junhua, Zhang Kojan, Richard Malvey, Denis Bauer, Michael Brunkhorst, Frank Glueck, Thomas Wolf, Timo Gomersall, Charles Kumar, Bharath Clarke, Mike Laffey, John Martin-Loeches, Ignacio Piva, Simone Shimizu, Naoki Phyu, Sabai Bonten, Marc Jong, Menno de Derde, Lennie Netea, Mihai Veerdonk, Frank van de McArthur, Colin McBride, Stephen McGuinness, Shay Morpeth, Susan Salisu-Kabara, Halima Sinclair, Jorge Arabi, Yaseen M. Kim, YaeJean Oh, Myoung-Don Baillie, Kenneth Dunning, Jake Fletcher, Tom Gobat, Nina Gordon, Anthony Horby, Peter McAuley, Danny Merson, Laura Williamson, Paula Blackwood, Bronagh Angus, Derek C. Berry, Scott Harhay, Michael Needham, Dale Uyeki, Tim Dat, Vu Quoc
author_role	author
author2	Murthy, Srinivas Diaz, Janet Cheng, Allen Denholm, Justin Hodgson, Carol Tong, Steven Webb, Steve Bozza, Fernando Augusto Adhikari, N. K. Foster, Nadine Fowler, Rob Turgeon, Alexis Xiaobin, Feng Ruijin, Qiu Lei, Shi Junhua, Zhang Kojan, Richard Malvey, Denis Bauer, Michael Brunkhorst, Frank Glueck, Thomas Wolf, Timo Gomersall, Charles Kumar, Bharath Clarke, Mike Laffey, John Martin-Loeches, Ignacio Piva, Simone Shimizu, Naoki Phyu, Sabai Bonten, Marc Jong, Menno de Derde, Lennie Netea, Mihai Veerdonk, Frank van de McArthur, Colin McBride, Stephen McGuinness, Shay Morpeth, Susan Salisu-Kabara, Halima Sinclair, Jorge Arabi, Yaseen M. Kim, YaeJean Oh, Myoung-Don Baillie, Kenneth Dunning, Jake Fletcher, Tom Gobat, Nina Gordon, Anthony Horby, Peter McAuley, Danny Merson, Laura Williamson, Paula Blackwood, Bronagh Angus, Derek C. Berry, Scott Harhay, Michael Needham, Dale Uyeki, Tim Dat, Vu Quoc
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
dc.contributor.author.fl_str_mv	Marshall, John C. Murthy, Srinivas Diaz, Janet Cheng, Allen Denholm, Justin Hodgson, Carol Tong, Steven Webb, Steve Bozza, Fernando Augusto Adhikari, N. K. Foster, Nadine Fowler, Rob Turgeon, Alexis Xiaobin, Feng Ruijin, Qiu Lei, Shi Junhua, Zhang Kojan, Richard Malvey, Denis Bauer, Michael Brunkhorst, Frank Glueck, Thomas Wolf, Timo Gomersall, Charles Kumar, Bharath Clarke, Mike Laffey, John Martin-Loeches, Ignacio Piva, Simone Shimizu, Naoki Phyu, Sabai Bonten, Marc Jong, Menno de Derde, Lennie Netea, Mihai Veerdonk, Frank van de McArthur, Colin McBride, Stephen McGuinness, Shay Morpeth, Susan Salisu-Kabara, Halima Sinclair, Jorge Arabi, Yaseen M. Kim, YaeJean Oh, Myoung-Don Baillie, Kenneth Dunning, Jake Fletcher, Tom Gobat, Nina Gordon, Anthony Horby, Peter McAuley, Danny Merson, Laura Williamson, Paula Blackwood, Bronagh Angus, Derek C. Berry, Scott Harhay, Michael Needham, Dale Uyeki, Tim Dat, Vu Quoc
dc.subject.en.pt_BR.fl_str_mv	COVID-19 SARS-CoV-2 Severe acute respiratory WHO Clinical Progression Scale
topic	COVID-19 SARS-CoV-2 Severe acute respiratory WHO Clinical Progression Scale
description	Fernando Bozza - Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
publishDate	2020
dc.date.accessioned.fl_str_mv	2020-07-31T00:50:31Z
dc.date.available.fl_str_mv	2020-07-31T00:50:31Z
dc.date.issued.fl_str_mv	2020
dc.type.status.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv	info:eu-repo/semantics/article
format	article
status_str	publishedVersion
dc.identifier.citation.fl_str_mv	MARSHALL, John C. et al. A minimal common outcome measure set for COVID-19 clinical research. The Lancet Infectious Diseases, v. 20, n. 8, p. 192-197, 2020.
dc.identifier.uri.fl_str_mv	https://www.arca.fiocruz.br/handle/icict/42482
dc.identifier.issn.pt_BR.fl_str_mv	1473-3099
dc.identifier.doi.none.fl_str_mv	10.1016/S1473-3099(20)30483-7
dc.identifier.eissn.pt_BR.fl_str_mv	1474-4457
identifier_str_mv	MARSHALL, John C. et al. A minimal common outcome measure set for COVID-19 clinical research. The Lancet Infectious Diseases, v. 20, n. 8, p. 192-197, 2020. 1473-3099 10.1016/S1473-3099(20)30483-7 1474-4457
url	https://www.arca.fiocruz.br/handle/icict/42482
dc.language.iso.fl_str_mv	eng
language	eng
dc.rights.driver.fl_str_mv	info:eu-repo/semantics/openAccess
eu_rights_str_mv	openAccess
dc.publisher.none.fl_str_mv	Elsevier
publisher.none.fl_str_mv	Elsevier
dc.source.none.fl_str_mv	reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ
instname_str	Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str	FIOCRUZ
institution	FIOCRUZ
reponame_str	Repositório Institucional da FIOCRUZ (ARCA)
collection	Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv	https://www.arca.fiocruz.br/bitstream/icict/42482/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/42482/2/A%20minimal_Fernando_Bozza_etal_INI_2020.pdf https://www.arca.fiocruz.br/bitstream/icict/42482/3/A%20minimal_Fernando_Bozza_etal_INI_2020.pdf.txt
bitstream.checksum.fl_str_mv	586c046dcfeef936e32f0323bb9a47c0 acf7a2557b3001ac49b59bfeb34b8cf2 bc400db2ca323915b46975a24368a4c2
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5
repository.name.fl_str_mv	Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv	repositorio.arca@fiocruz.br
_version_	1798324903537016832

A minimal common outcome measure set for COVID-19 clinical research

Registros relacionados